Gamma-glutamyl metformin inhibits renal cell carcinoma progression by activating AMPK signaling pathway.
Saved in:
| Title: | Gamma-glutamyl metformin inhibits renal cell carcinoma progression by activating AMPK signaling pathway. |
|---|---|
| Authors: | Lv Z; Department of Urology, Central Hospital, Tianjin University/Tianjin Third Central Hospital, Tianjin, China.; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin, China., Zhang LS; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, China., Aisha A; The Third Central Clinical College of Tianjin Medical University, Tianjin, China., Wang TH; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, China., Cui HY; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, China., Tang S; Department of Urology, Central Hospital, Tianjin University/Tianjin Third Central Hospital, Tianjin, China., Zhang JH; Department of Urology, Central Hospital, Tianjin University/Tianjin Third Central Hospital, Tianjin, China., Chang F; Department of Urology, Central Hospital, Tianjin University/Tianjin Third Central Hospital, Tianjin, China., Wu WS; Department of Urology, Affiliated Hospital of Jianghan University, Wuhan, China., Li LY; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, China., Zhang ZS; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin, China.; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, China., Chen FM; Department of Urology, Central Hospital, Tianjin University/Tianjin Third Central Hospital, Tianjin, China.; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin, China.; Department of Urology, Affiliated Hospital of Jianghan University, Wuhan, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 May 07; Vol. 17, pp. 1807987. Date of Electronic Publication: 2026 May 07 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2026.1807987 |
